New Collaborative Research Program To Help Advance Ppersonalized Medicine

Burnham Institute for Medical Research and the Sarah W Stedman Nutrition and Metabolism Center at Duke University Medical Center have reported a new collaborative research program that will use the power of metabolomic profiling to help advance the concept of personalised medicine.

Reportedly, the research agreement will establish an extension of Duke’s Stedman Center laboratory at Burnham’s Lake Nona campus in Orlando. The collaboration, which will begin in the fall, will clarify the basic mechanisms of disease and identify biomarkers for disease diagnosis and drug action.

Under the collaboration, Stedman Center scientists will join Burnham researchers at the Lake Nona campus to establish a series of assays for specific metabolites. It is envisioned this technology platform will promote collaborative studies between the Stedman Center and Burnham.

Christopher Newgard, director of the Stedman Center and W David and Sarah Stedman professor in the department of pharmacology & cancer biology at Duke Medical Center, said: “At the Stedman Center, we have been developing sophisticated tools for metabolic profiling for the past six years. Now we have an opportunity to share and further develop those tools and their applications with a major emergent program in metabolic disease research at the Burnham, Lake Nona campus.